drugset / Trial / NCT00767494

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

NCT00767494

Phase 3 Terminated 17 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare the IOP lowering efficacy of Travoprost/Brinzolamide dosed daily in the morning or evening, vs TRAVATAN dosed once daily in the evening, and vs. AZOPT dosed BID in patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2008-10
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brinzolamide Small molecule Other
Comparator Travoprost Other / unclassified Other